The Cryptococcus neoformans capsule: A sword and a shield

Clinical Microbiology Reviews

Volumn 25, Issue 3, 2012, Pages 387-408

  O'Meara, Teresa R ^a   Andrew Alspaugh, J ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; CHITIN; CHITOSAN; CYCLIC AMP; GLUCAN; GLUCOSE; GLUCURONOXYLOMANNAN; MITOGEN ACTIVATED PROTEIN KINASE; MONOMER; NITROGEN;

ACETYLATION; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIAL MEMBRANE; BACTERIAL SECRETION SYSTEM; BIOACCUMULATION; BIOSYNTHESIS; CARBOHYDRATE METABOLISM; CELL ADHESION; CELL ENCAPSULATION; CHEMICAL MODIFICATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CRYPTOCOCCUS NEOFORMANS; ENVIRONMENTAL TEMPERATURE; HYPOXIA; MASS SPECTROMETRY; MICROENVIRONMENT; MOLECULAR DYNAMICS; NONHUMAN; OXIDATIVE STRESS; PH; PHENOTYPE; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADAPTATION, PHYSIOLOGICAL; CELL WALL; CHITIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; HOST-PARASITE INTERACTIONS; HUMANS; POLYSACCHARIDES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

FILOBASIDIELLA NEOFORMANS;

EID: 84863702088     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00001-12     Document Type: Review

References (230)

1. Adams DJ. 2004. Fungal cell wall chitinases and glucanases. Microbiology 150:2029-2035.
2. Adler A, et al. 2011. A novel specificity protein 1 (SP1)-like gene regulating protein kinase C-1 (Pkc1)-dependent cell wall integrity and virulence factors in Cryptococcus neoformans. J. Biol. Chem. 286:20977-20990.
3. Alspaugh J, Perfect J, Heitman J. 1997. Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev. 11:3206-3217.
4. Alspaugh J, Perfect JR, Heitman J. 1998. Signal transduction pathways regulating differentiation and pathogenicity of Cryptococcus neoformans. Fungal Genet. Biol. 25:1-14.
5. Alspaugh J, et al. 2002. Adenylyl cyclase functions downstream of the G-alpha protein Gpa1 and controls mating and pathogenicity of Cryptococcus neoformans. Eukaryot. Cell 1:75-84.
6. Arst HN, Bignell E, Tilburn J. 1994. Two new genes involved in signaling ambient pH in Aspergillus nidulans. Mol. Gen. Genet. 245:787-790.
7. Baek Y, Li M, Davis D. 2008. Candida albicans ferric reductases are differentially regulated in response to distinct forms of iron limitation by the Rim101 and CBF transcription factors. Eukaryot. Cell 7:1168-1179.
8. Baek Y-U, Martin SJ, Davis DA. 2006. Evidence for novel pHdependent regulation of Candida albicans Rim101, a direct transcriptional repressor of the cell wall beta-glycosidase Phr2. Eukaryot. Cell 5:1550-1559.
9. Bahn Y, Hicks J, Giles S, Cox G, Heitman J. 2004. Adenylyl cyclaseassociated protein AcaI regulates virulence and differentiation of Cryptococcus neoformans via the cyclic AMP-protein kinase A cascade. Eukaryot. Cell 3:1476-1491.
10. Bahn Y, Kojima K, Cox G, Heitman J. 2005. Specialization of the HOG pathway and its impact on differentiation and virulence of Cryptococcus neoformans. Mol. Biol. Cell 16:2285-2300.
11. Bahn Y-S, Cox GM, Perfect JR, Heitman J. 2005. Carbonic anhydrase and CO2 sensing during Cryptococcus neoformans growth, differentiation, and virulence. Curr. Biol. 15:2013-2020.
12. Bahn Y-S, Geunes-Boyer S, Heitman J. 2007. Ssk2 mitogen-activated protein kinase kinase kinase governs divergent patterns of the stressactivated Hog1 signaling pathway in Cryptococcus neoformans. Eukaryot. Cell 6:2278-2289.
13. Bahn Y-S, Kojima K, Cox GM, Heitman J. 2006. A unique fungal two-component system regulates stress responses, drug sensitivity, sexual development, and virulence of Cryptococcus neoformans. Mol. Biol. Cell 17:3122-3135.
14. Baker LG, Specht CA, Donlin MJ, Lodge JK. 2007. Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot. Cell 6:855-867.
15. Baker LG, Specht CA, Lodge JK. 2011. Cell wall chitosan is necessary for virulence in the opportunistic pathogen Cryptococcus neoformans. Eukaryot. Cell 10:1264-1268.
16. Baker LG, Specht CA, Lodge JK. 2009. Chitinases are essential for sexual development but not vegetative growth in Cryptococcus neoformans. Eukaryot. Cell 8:1692-1705.
17. Ballou ER, Nichols CB, Miglia KJ, Kozubowski L, Alspaugh JA. 2010. Two CDC42 paralogues modulate Cryptococcus neoformans thermotolerance and morphogenesis under host physiological conditions. Mol. Microbiol. 75:763-780.
18. Banks IR, et al. 2005. A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot. Cell 4:1902-1912.
19. Bar-Peled M, Griffith CL, Doering TL. 2001. Functional cloning and characterization of a UDP-glucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis. Proc. Natl. Acad. Sci. U. S. A. 98:12003-12008.
20. Bensen E, Martin SJ, Li M, Berman J, Davis DA. 2004. Transcriptional profiling in Candida albicans reveals new adaptive responses to extracellular pH and functions for Rim101p. Mol. Microbiol. 54:1335-1351.
21. Bhattacharjee AK, Bennett JE, Glaudemans CPJ. 1984. Capsular polysaccharides of Cryptococcus neoformans. Rev. Infect. Dis. 6:619-624.
22. Bignell E, et al. 2005. The Aspergillus pH-responsive transcription factor PacC regulates virulence. Mol. Microbiol. 55:1072-1084.
23. Blanchin-Roland S, Da Costa G, Gaillardin C. 2008. Ambient pH signalling in the yeast Yarrowia lipolytica involves YlRim23p/PalC, which interacts with Snf7p/Vps32p, but does not require the long C terminus of YlRim9p/PalI. Microbiology 154:1668-1676.
24. Blankenship JR, Fanning S, Hamaker JJ, Mitchell AP. 2010. An extensive circuitry for cell wall regulation in Candida albicans. PLoS Pathog. 6:e1000752. doi:10.1371/journal.ppat.1000752.
25. Bulik DA, et al. 2003. Chitin synthesis in Saccharomyces cerevisiae in response to supplementation of growth medium with glucosamine and cell wall stress. Eukaryot. Cell 2:886-900.
26. Byrnes EJ, III, et al. 2009. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J. Infect. Dis. 199:1081-1086.
27. Calcagno-Pizarelli AM, et al. 2007. Establishment of the ambient pH signaling complex in Aspergillus nidulans: PalI assists plasma membrane localization of PalH. Eukaryot. Cell 6:2365-2375.
28. Castle SA, et al. 2008. Beta 1,2-xylosyltransferase Cxt1p is solely responsible for xylose incorporation into Cryptococcus neoformans glycosphingolipids. Eukaryot. Cell 7:1611-1615.
29. Chang YC, Bien CM, Lee H, Espenshade PJ, Kwon-Chung KJ. 2007. Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans. Mol. Microbiol. 64:614-629.
30. Chang YC, Ingavale SS, Bien C, Espenshade P, Kwon-Chung KJ. 2009. Conservation of the sterol regulatory element-binding protein pathway and its pathobiological importance in Cryptococcus neoformans. Eukaryot. Cell 8:1770-1779.
31. Chang YC, Jong A, Huang S, Zerfas P, Kwon-Chung KJ. 2006. CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans. Infect. Immun. 74:3930-3938.
32. Chang YC, Kwon-Chung KJ. 1994. Complementation of a capsuledeficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14:4912-4919.
33. Chang YC, Penoyer LA, Kwon-Chung KJ. 1996. The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect. Immun. 64:1977-1983.
34. Chang YC, Penoyer LA, Kwon-Chung KJ. 2001. The second STE12 homologue of Cryptococcus neoformans is MATa-specific and plays an important role in virulence. Proc. Natl. Acad. Sci. U. S. A. 98:3258-3263.
35. Chang YC, Wickes BL, Miller GF, Penoyer LA, Kwon-Chung KJ. 2000. Cryptococcus neoformans STE12-alpha regulates virulence but is not essential for mating. J. Exp. Med. 191:871-882.
36. Charlier C, et al. 2005. Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am. J. Pathol. 166:421-432.
37. Cheon SA, Jung Chen K-W, Heitman Y-LJ, Bahn Y-S, Kang HA. 2011. Unique evolution of the UPR pathway with a novel bZIP transcription factor, Hxl1, for controlling pathogenicity of Cryptococcus neoformans. PLoS Pathog. 7:e1002177. doi:10.1371/journal.ppat.1002177.
38. Chikamori M, Fukushima K. 2005. A new hexose transporter from Cryptococcus neoformans: molecular cloning and structural and functional characterization. Fungal Genet. Biol. 42:646-655.
39. Chrisman CJ, Albuquerque P, Guimaraes AJ, Nieves E, Casadevall A. 2011. Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages. PLoS Pathog. 7:e1002047. doi:10.1371/journal.ppat.1002047.
40. Chun CD, Brown JCS, Madhani HD. 2011. A major role for capsuleindependent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans. Cell Host Microbe 9:243-251.
41. Chun CD, Liu OW, Madhani HD. 2007. A link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen Cryptococcus neoformans. PLoS Pathog. 3:e22. doi:10.1371/journal.ppat.0030022.
42. Chun CD, Madhani HD. 2010. Ctr2 links copper homeostasis to polysaccharide capsule formation and phagocytosis inhibition in the human fungal pathogen Cryptococcus neoformans. PLoS One 5:e12503. doi:10.1371/journal.pone.0012503.
43. Cleare W, Casadevall A. 1999. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release. Med. Mycol. 37:235-243.
44. Coenjaerts FEJ, et al. 2006. The Skn7 response regulator of Cryptococcus neoformans is involved in oxidative stress signalling and augments intracellular survival in endothelium. FEMS Yeast Res. 6:652-661.
45. Cordero RJB, Frases S, Guimaräes AJ, Rivera J, Casadevall A. 2011. Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity. Mol. Microbiol. 79:1101-1117.
46. Cornet M, et al. 2005. Deletions of endocytic components VPS28 and VPS32 affect growth at alkaline pH and virulence through both RIM101-dependent and RIM101-independent pathways in Candida albicans. Infect. Immun. 73:7977-7987.
47. Cornet M, Richard ML, Gaillardin C. 2009. The homologue of the Saccharomyces cerevisiae RIM9 gene is required for ambient pH signaling in Candida albicans. Res. Microbiol. 160:219-223.
48. Cottrell TR, Griffith CL, Liu H, Nenninger AA, Doering TL. 2007. The pathogenic fungus Cryptococcus neoformans expresses two functional GDP-mannose transporters with distinct expression patterns and roles in capsule synthesis. Eukaryot. Cell 6:776-785.
49. Cramer KL, Gerrald QD, Nichols CB, Price MS, Alspaugh JA. 2006. Transcription factor Nrg1 mediates capsule formation, stress response, and pathogenesis in Cryptococcus neoformans. Eukaryot. Cell 5:1147-1156.
50. Cross C, Bancroft G. 1995. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect. Immun. 63:2604-2611.
51. Davidson RC, Nichols CB, Cox GM, Perfect JR, Heitman J. 2003. A MAP kinase cascade composed of cell type specific and non-specific elements controls mating and differentiation of the fungal pathogen Cryptococcus neoformans. Mol. Microbiol. 49:469-485.
52. Davis D, Wilson RB, Mitchell AP. 2000. RIM101-dependent and -independent pathways governpHresponses in Candida albicans. Mol. Cell. Biol. 20:971-978.
53. De Jesus M, Chow S-K, Cordero RJB, Frases S, Casadevall A. 2010. Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable. Eukaryot. Cell 9:1018-1028.
54. Diez E, et al. 2002. Activation of the Aspergillus PacC zinc finger transcription factor requires two proteolytic steps. EMBO J. 21:1350-1359.
55. Ding C, et al. 2011. The copper regulon of the human fungal pathogen Cryptococcus neoformans H99. Mol. Microbiol. 81:1560-1576.
56. Doering TL. 2009. How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu. Rev. Microbiol. 63:223-247.
57. Doering TL. 1999. A unique alpha-1,3 mannosyltransferase of the pathogenic fungus Cryptococcus neoformans. J. Bacteriol. 181:5482-5488.
58. Dromer F, Gueho E, Ronin O, Dupont B. 1993. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide. J. Clin. Microbiol. 31:359-363.
59. D'Souza CA, et al. 2001. Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol. Cell. Biol. 21:3179-3191.
60. Dykstra MA, Friedman L, Murphy JW. 1977. Capsule size of Cryptococcus neoformans: control and relationship to virulence. Infect. Immun. 16:129-135.
61. Eckert TF, Kozel TR. 1987. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide. Infect. Immun. 55:1895-1899.
62. Erickson T, et al. 2001. Multiple virulence factors of Cryptococcus neoformans are dependent on VPH1. Mol. Microbiol. 42:1121-1131.
63. Feldmesser M, Harris C, Reichberg S, Khan S, Casadevall A. 1996. Serum cryptococcal antigen in patients with AIDS. Clin. Infect. Dis. 23: 827-830.
64. Feldmesser M, Kress Y, Casadevall A. 2001. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147:2355-2365.
65. Feldmesser M, Rivera J, Kress Y, Kozel TR, Casadevall A. 2000. Antibody interactions with the capsule of Cryptococcus neoformans. Infect. Immun. 68:3642-3650.
66. Fonseca FL, et al. 2009. Role for chitin and chitooligomers in the capsular architecture of Cryptococcus neoformans. Eukaryot. Cell 8:1543-1553.
67. Frases S, Nimrichter L, Viana NB, Nakouzi A, Casadevall A. 2008. Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot. Cell 7:319-327.
68. Frases S, et al. 2009. Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules. Proc. Natl. Acad. Sci. U. S. A. 106:1228-1233.
69. Garcia-Rivera J, Chang YC, Kwon-Chung KJ, Casadevall A. 2004. Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot. Cell 3:385-392.
70. Garcia-Rodas R, Casadevall A, Rodriguez-Tudela JL, Cuenca-Estrella M, Zaragoza O. 2011. Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection. PLoS One 6:e24485. doi:10.1371/journal.pone.0024485.
71. Gates MA, Thorkildson P, Kozel TR. 2004. Molecular architecture of the Cryptococcus neoformans capsule. Mol. Microbiol. 52:13-24.
72. Gates-Hollingsworth MA, Kozel TR. 2009. Phenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsule. Mol. Microbiol. 74:126-138.
73. Gerik KJ, Bhimireddy SR, Ryerse JS, Specht CA, Lodge JK. 2008. PKC1 is essential for protection against both oxidative and nitrosative stresses, cell integrity, and normal manifestation of virulence factors in the pathogenic fungus Cryptococcus neoformans. Eukaryot. Cell 7:1685-1698.
74. Gerik KJ, et al. 2005. Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans. Mol. Microbiol. 58: 393-408.
75. Gilbert NM, et al. 2010. KRE genes are required for β-1,6-glucan synthesis, maintenance of capsule architecture and cell wall protein anchoring in Cryptococcus neoformans. Mol. Microbiol. 76:517-534.
76. Goldman DL, et al. 2001. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 107:e66. doi:10.1542/peds.107.5.e66.
77. Granger DL, Perfect JR, Durack DT. 1985. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J. Clin. Invest. 76:508-516.
78. Griffith CL, Klutts JS, Zhang L, Levery SB, Doering TL. 2004. UDPglucose dehydrogenase plays multiple roles in the biology of the pathogenic fungus Cryptococcus neoformans. J. Biol. Chem. 279:51669-51676.
79. Grijpstra J, Gerwig GJ, Wosten H, Kamerling JP, de Cock H. 2009. Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans. Eukaryot. Cell 8:1165-1173.
80. Guimarães AJ, et al. 2010. Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo. Cell. Microbiol. 12:740-753.
81. Hayashi M, Fukuzawa T, Sorimachi H, Maeda T. 2005. Constitutive activation of the pH-responsive Rim101 pathway in yeast mutants defective in late steps of the MVB/ESCRT pathway. Mol. Cell. Biol. 25:9478-9490.
82. Haynes BC, et al. 2011. Toward an integrated model of capsule regulation in Cryptococcus neoformans. PLoS Pathog. 7:e1002411. doi:10.1371/journal.ppat.1002411.
83. Heiss C, Klutts JS, Wang Z, Doering TL, Azadi P. 2009. The structure of Cryptococcus neoformans galactoxylomannan contains beta-Dglucuronic acid. Carbohydr. Res. 344:915-920.
84. Herrador A, Herranz S, Lara D, Vincent O. 2010. Recruitment of the ESCRT machinery to a putative seven-transmembrane-domain receptor is mediated by an arrestin-related protein. Mol. Cell. Biol. 30:897-907.
85. Herranz S, et al. 2005. Arrestin-related proteins mediate pH signaling in fungi. Proc. Natl. Acad. Sci. U. S. A. 102:12141-12146.
86. Hervas-Aguilar A, Galindo A, Penalva MA. 2010. Receptorindependent ambient pH signaling by ubiquitin attachment to fungal arrestin-like PalF. J. Biol. Chem. 285:18095-18102.
87. Hervas-Aguilar A, Rodriguez JM, Tilburn J, Arst HN, Penalva MA. 2007. Evidence for the direct involvement of the proteasome in the proteolytic processing of the Aspergillus nidulans zinc finger transcription factor PacC. J. Biol. Chem. 282:34735-34747.
88. Heung LJ, Kaiser AE, Luberto C, Del Poeta M. 2005. The role and mechanism of diacylglycerol-protein kinase C1 signaling in melanogenesis by Cryptococcus neoformans. J. Biol. Chem. 280:28547-28555.
89. Heung LJ, Luberto C, Plowden A, Hannun YA, Del Poeta M. 2004. The sphingolipid pathway regulates Pkc1 through the formation of diacylglycerol in Cryptococcus neoformans. J. Biol. Chem. 279:21144-21153.
90. Hicks JK, Bahn Y-S, Heitman J. 2005. Pde1 phosphodiesterase modulates cyclic AMP levels through a protein kinase A-mediated negative feedback loop in Cryptococcus neoformans. Eukaryot. Cell 4:1971-1981.
91. Hicks JK, D'Souza CA, Cox GM, Heitman J. 2004. Cyclic AMPdependent protein kinase catalytic subunits have divergent roles in virulence factor production in two varieties of the fungal pathogen Cryptococcus neoformans. Eukaryot. Cell 3:14-26.
92. Hu G, et al. 2007. Transcriptional regulation by protein kinase A in Cryptococcus neoformans. PLoS Pathog. 3:e42. doi:10.1371/journal.ppat.0030042.
93. Huang C, Nong S-H, Mansour MK, Specht CA, Levitz SM. 2002. Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-cell responses. Infect. Immun. 70:5485-5493.
94. Hwang LH, Mayfield JA, Rine J, Sil A. 2008. Histoplasma requires SID1, a member of an iron-regulated siderophore gene cluster, for host colonization. PLoS Pathog. 4:e1000044. doi:10.1371/journal.ppat.1000044.
95. Idnurm A, Walton FJ, Floyd A, Reedy JL, Heitman J. 2009. Identification of ENA1 as a virulence gene of the human-pathogenic fungus Cryptococcus neoformans through signature-tagged insertional mutagenesis. Eukaryot. Cell 8:315-326.
96. Jacobson ES, Payne WR. 1982. UDP glucuronate decarboxylase and synthesis of capsular polysaccharide in Cryptococcus neoformans. J. Bacteriol. 152:932-934.
97. James PG, Cherniak R, Jones RG, Stortz CA, Reiss E. 1990. Cell-wall glucans of Cryptococcus neoformans CAP 67. Carbohydr. Res. 198:23-38.
98. Janbon G, Himmelreich U, Moyrand F, Improvisi L, Dromer F. 2001. Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide. Mol. Microbiol. 42:453-467.
99. Jarvis JN, et al. 2011. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIVassociated cryptococcal meningitis. Clin. Infect. Dis. 53:1019-1023.
100. Jbel M, Mercier A, Pelletier B, Beaudoin J, Labbe S. 2009. Iron activates in vivo DNA binding of Schizosaccharomyces pombe transcription factor Fep1 through its amino-terminal region. Eukaryot. Cell 8:649-664.
101. Jong A, et al. 2008. Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells requires protein kinase C activation. Cell. Microbiol. 10:1854-1865.
102. Jong A, et al. 2007. Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection. Eukaryot. Cell 6:1486-1496.
103. Jung W, Kronstad J. 2011. The iron-responsive, GATA-type transcription factor Cir1 influences mating in Cryptococcus neoformans. Mol. Cells 31:73-77.
104. Jung WH, Kronstad JW. 2008. Iron and fungal pathogenesis: a case study with Cryptococcus neoformans. Cell. Microbiol. 10:277-284.
105. Jung WH, Kronstad JW. 2011. Iron influences the abundance of the iron regulatory protein Cir1 in the fungal pathogen Cryptococcus neoformans. FEBS Lett. 585:3342-3347.
106. Jung WH, et al. 2010. HapX positively and negatively regulates the transcriptional response to iron deprivation in Cryptococcus neoformans. PLoS Pathog. 6:e1001209. doi:10.1371/journal.ppat.1001209.
107. Jung WH, et al. 2008. Iron source preference and regulation of iron uptake in Cryptococcus neoformans. PLoS Pathog. 4:e45. doi:10.1371/journal.ppat.0040045.
108. Jung WH, Sham A, White R, Kronstad JW. 2006. Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans. PLoS Biol. 4:e410. doi:10.1371/journal.pbio.0040410.
109. Kim MS, et al. 2010. Comparative transcriptome analysis of the CO2 sensing pathway via differential expression of carbonic anhydrase in Cryptococcus neoformans. Genetics 185:1207-1219.
110. Kim S-Y, et al. 2011. Hrk1 plays both Hog1-dependent and -independent roles in controlling stress response and antifungal drug resistance in Cryptococcus neoformans. PLoS One 6:e18769. doi:10.1371/journal.pone.0018769.
111. Kingsbury JM, Yang Z, Ganous TM, Cox GM, McCusker JH. 2004. Cryptococcus neoformans Ilv2p confers resistance to sulfometuron methyl and is required for survival at 37C and in vivo. Microbiology 150:1547-1558.
112. Klengel T, et al. 2005. Fungal adenylyl cyclase integrates CO2 sensing with cAMP signaling and virulence. Curr. Biol. 15:2021-2026.
113. Klutts JS, Doering TL. 2008. Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides. J. Biol. Chem. 283:14327-14334.
114. Klutts JS, Levery SB, Doering TL. 2007. A beta-1,2-xylosyltransferase from Cryptococcus neoformans defines a new family of glycosyltransferases. J. Biol. Chem. 282:17890-17899.
115. Kmetzsch L, et al. 2011. Role for Golgi reassembly and stacking protein (GRASP) in polysaccharide secretion and fungal virulence. Mol. Microbiol. 81:206-218.
116. Kmetzsch L, et al. 2011. The GATA-type transcriptional activator Gat1 regulates nitrogen uptake and metabolism in the human pathogen Cryptococcus neoformans. Fungal Genet. Biol. 48:192-199.
117. Ko Y-J, et al. 2009. Remodeling of global transcription patterns of Cryptococcus neoformans genes mediated by the stress-activated HOG signaling pathways. Eukaryot. Cell 8:1197-1217.
118. Kozel TR, et al. 2003. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O-acetylation or xylosyl side chains. Infect. Immun. 71:2868-2875.
119. Kraus PR, Fox DS, Cox GM, Heitman J. 2003. The Cryptococcus neoformans MAP kinase Mpk1 regulates cell integrity in response to antifungal drugs and loss of calcineurin function. Mol. Microbiol. 48:1377-1387.
120. Kwon-Chung KJ, Boekhout T, Fell JW, Diaz M. 2002. Proposal (1557) to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae), vol 51. International Association for Plant Taxonomy, Vienna, Austria.
121. Lamb T, Xu W, Diamond A, Mitchell AP. 2001. Alkaline response genes of Saccharomyces cerevisiae and their relationship to the RIM101 pathway. J. Biol. Chem. 276:1850-1856.
122. Lee A, et al. 2010. Survival defects of Cryptococcus neoformans mutants exposed to human cerebrospinal fluid result in attenuated virulence in an experimental model of meningitis. Infect. Immun. 78:4213-4225.
123. Lee H, Chang YC, Varma A, Kwon-Chung KJ. 2009. Regulatory diversity of TUP1 in Cryptococcus neoformans. Eukaryot. Cell 8:1901-1908.
124. Lee IR, Chow EWL, Morrow CA, Djordjevic JT, Fraser JA. 2011. Nitrogen metabolite repression of metabolism and virulence in the human fungal pathogen Cryptococcus neoformans. Genetics 188:309-323.
125. Lee J-W, Ko Y-J, Kim S-Y, Bahn Y-S. 2011. Multiple roles of Ypd1 phosphotransfer protein in viability, stress response, and virulence factor regulation in Cryptococcus neoformans. Eukaryot. Cell 10:998-1002.
126. Levitz SM, Nong S-H, Mansour MK, Huang C, Specht CA. 2001. Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proc. Natl. Acad. Sci. U. S. A. 98:10422-10427.
127. Li L, et al. 2007. Canonical heterotrimeric G proteins regulating mating and virulence of Cryptococcus neoformans. Mol. Biol. Cell 18:4201-4209.
128. Li M, Martin SJ, Bruno VM, Mitchell AP, Davis DA. 2004. Candida albicans Rim13p, a protease required for Rim101p processing at acidic and alkaline pHs. Eukaryot. Cell 3:741-751.
129. Li W, Mitchell AP. 1997. Proteolytic activation of Rim1p, a positive regulator of yeast sporulation and invasive growth. Genetics 145:63-73.
130. Li Z, Sun Z, Li D, Pan J, Zhu X. 2011. Identification of a Zds-like gene ZDS3 as a new mediator of stress resistance, capsule formation and virulence of the human pathogenic yeast Cryptococcus neoformans. FEMS Yeast Res. 11:529-539.
131. Lian T, et al. 2005. Iron-regulated transcription and capsule formation in the fungal pathogen Cryptococcus neoformans. Mol. Microbiol. 55: 1452-1472.
132. Liu OW, et al. 2008. Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 135:174-188.
133. Liu OW, Kelly MJS, Chow ED, Madhani HD. 2007. Parallel beta-helix proteins required for accurate capsule polysaccharide synthesis and virulence in the yeast Cryptococcus neoformans. Eukaryot. Cell 6:630-640.
134. Luo RX, Dean DC. 1999. Chromatin remodeling and transcriptional regulation. J. Natl. Cancer Inst. 91:1288-1294.
135. Maeng S, et al. 2010. Comparative transcriptome analysis reveals novel roles of the Ras- and cAMP-signaling pathways in environmental stress response and antifungal drug sensitivity in Cryptococcus neoformans. Eukaryot. Cell 9:360-378.
136. Maligie MA, Selitrennikoff CP. 2005. Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins. Antimicrob. Agents Chemother. 49:2851-2856.
137. Marion CL, et al. 2006. An alpha-(1,4)-amylase is essential for alpha-(1,3)-glucan production and virulence in Histoplasma capsulatum. Mol. Microbiol. 62:970-983.
138. Mas G, et al. 2009. Recruitment of a chromatin remodelling complex by the Hog1 MAP kinase to stress genes. EMBO J. 28:326-336.
139. McClelland EE, Nicola AM, Prados-Rosales R, Casadevall A. 2010. Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. J. Clin. Invest. 120:1355-1361.
140. McFadden DC, De Jesus M, Casadevall A. 2006. The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction. J. Biol. Chem. 281:1868-1875.
141. McFadden DC, Fries BC, Wang F, Casadevall A. 2007. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot. Cell 6:1464-1473.
142. Mingot JM, Espeso EA, Diez E, Penalva MA. 2001. Ambient pH signaling regulates nuclear localization of the Aspergillus nidulans PacC transcription factor. Mol. Cell. Biol. 21:1688-1699.
143. Mogensen EG, et al. 2006. Cryptococcus neoformans senses CO2 through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1. Eukaryot. Cell 5:103-111.
144. Momany M, et al. 2004. The Aspergillus fumigatus cell wall is organized in domains that are remodelled during polarity establishment. Microbiology 150:3261-3268.
145. Moyrand F, Chang YC, Himmelreich U, Kwon-Chung KJ, Janbon G. 2004. Cas3p belongs to a seven-member family of capsule structure designer proteins. Eukaryot. Cell 3:1513-1524.
146. Moyrand F, Janbon G. 2004. UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37 degreesC and for capsule biosynthesis. Eukaryot. Cell 3:1601-1608.
147. Moyrand F, Klaproth B, Himmelreich U, Dromer F, Janbon G. 2002. Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans. Mol. Microbiol. 45:837-849.
148. Moyrand F, Lafontaine I, Fontaine T, Janbon G. 2008. UGE1 and UGE2 regulate the UDP-glucose/UDP-galactose equilibrium in Cryptococcus neoformans. Eukaryot. Cell 7:2069-2077.
149. Moyrand F, Fontaine T, Janbon G. 2007. Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol. Microbiol. 64:771-781.
150. Mylonakis E, Ausubel FM, Perfect JR, Heitman J, Calderwood SB. 2002. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 99:15675-15680.
151. Nimrichter L, et al. 2007. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryot. Cell 6:1400-1410.
152. Okagaki LH, et al. 2010. Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog. 6:e1000953. doi:10.1371/journal.ppat.1000953.
153. Okagaki LH, et al. 2011. Cryptococcal titan cell formation is regulated by G-protein signaling in response to multiple stimuli. Eukaryot. Cell 10:1306-1316.
154. Oliveira DL, et al. 2009. Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan. Fungal Genet. Biol. 46:956-963.
155. O'Meara TR, Hay C, Price MS, Giles S, Alspaugh JA. 2010. Cryptococcus neoformans histone acetyltransferase Gcn5 regulates fungal adaptation to the host. Eukaryot. Cell 9:1193-1202.
156. O'Meara TR, et al. 2010. Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule. PLoS Pathog. 6:e1000776. doi:10.1371/journal.ppat.1000776.
157. Orejas M, et al. 1995. Activation of the Aspergillus PacC transcription factor in response to alkaline ambient pH requires proteolysis of the carboxy-terminal moiety. Genes Dev. 9:1622-1632.
158. Palmer DA, et al. 2006. Gib2, a novel gbeta-like/RACK1 homolog, functions as a gbeta subunit in cAMP signaling and is essential in Cryptococcus neoformans. J. Biol. Chem. 281:32596-32605.
159. Panepinto J, et al. 2009. Sec6-dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans. Mol. Microbiol. 71: 1165-1176.
160. Panepinto JC, et al. 2007. Binding of serum mannan binding lectin to a cell integrity-defective Cryptococcus neoformans ccr4 delta mutant. Infect. Immun. 75:4769-4779.
161. Park BJ, et al. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525-530.
162. Pascon RC, Ganous TM, Kingsbury JM, Cox GM, McCusker JH. 2004. Cryptococcus neoformans methionine synthase: expression analysis and requirement for virulence. Microbiology 150:3013-3023.
163. Pelletier B, Beaudoin J, Mukai Y, Labbé S. 2002. Fep1, an iron sensor regulating iron transporter gene expression in Schizosaccharomyces pombe. J. Biol. Chem. 277:22950-22958.
164. Pelletier B, et al. 2007. Expression of Candida albicans Sfu1 in fission yeast complements the loss of the iron-regulatory transcription factor Fep1 and requires Tup co-repressors. Yeast 24:883-900.
165. Penas MM, et al. 2007. Further characterization of the signaling proteolysis step in the Aspergillus nidulans pH signal transduction pathway. Eukaryot. Cell 6:960-970.
166. Pierini LM, Doering TL. 2001. Spatial and temporal sequence of capsule construction in Cryptococcus neoformans. Mol. Microbiol. 41:105-115.
167. Proft M, et al. 2001. Regulation of the Sko1 transcriptional repressor by the Hog1 MAP kinase in response to osmotic stress. EMBO J. 20:1123-1133.
168. Proft M, Struhl K. 2002. Hog1 kinase converts the Sko1-Cyc8-Tup1 repressor complex into an activator that recruits SAGA and SWI/SNF in response to osmotic stress. Mol. Cell 9:1307-1317.
169. Protchenko O, et al. 2001. Three cell wall mannoproteins facilitate the uptake of iron in Saccharomyces cerevisiae. J. Biol. Chem. 276:49244-49250.
170. Pukkila-Worley R, et al. 2005. Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade. Eukaryot. Cell 4:190-201.
171. Rappleye CA, Eissenberg LG, Goldman WE. 2007. Histoplasma capsulatum β-(1,3)-glucan blocks innate immune recognition by the β-glucan receptor. Proc. Natl. Acad. Sci. 104:1366-1370.
172. Reese AJ, Doering TL. 2003. Cell wall alpha1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol. Microbiol. 50:1401-1409.
173. Reese AJ, et al. 2007. Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence. Mol. Microbiol. 63: 1385-1398.
174. Retini C, Vecchiarelli A, Monari C, Bistoni F, Kozel TR. 1998. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes. Infect. Immun. 66:664-669.
175. Richardson DW, Wasserman AJ, Patterson JL. 1961. General and regional circulatory responses to change in blood pH and carbon dioxide tension. J. Clin. Invest. 40:31-43.
176. Rinaldi MG, et al. 1986. Serotypes of Cryptococcus neoformans in
177. Rodrigues ML, et al. 2008. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot. Cell 7:58-67.
178. Rodrigues ML, et al. 2007. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal transcell wall transport. Eukaryot. Cell 6:48-59.
179. Sakaguchi N, Baba T, Fukuzawa M, Ohno S. 1993. Ultrastructural study of Cryptococcus neoformans by quick-freezing and deep-etching method. Mycopathologia 121:133-141.
180. Shen G, Wang Y-L, Whittington A, Li L, Wang P. 2008. The RGS protein Crg2 regulates pheromone and cyclic AMP signaling in Cryptococcus neoformans. Eukaryot. Cell 7:1540-1548.
181. Shen G, Whittington A, Song K, Wang P. 2010. Pleiotropic function of intersectin homologue Cin1 in Cryptococcus neoformans. Mol. Microbiol. 76:662-676.
182. Shen G, Whittington A, Wang P. 2011. Wsp1, a GBD/CRIB domaincontaining WASP homolog, is required for growth, morphogenesis, and virulence of Cryptococcus neoformans. Eukaryot. Cell 10:521-529.
183. Siafakas AR, et al. 2007. Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity. J. Biol. Chem. 282:37508-37514.
184. Sims W. 1986. Effect of carbon dioxide on the growth and form of Candida albicans. J. Med. Microbiol. 22:203-208.
185. Singh N, Perfect JR. 2007. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect. Dis. 7:395-401.
186. Small JM, Mitchell TG. 1986. Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants. Infect. Immun. 54:742-750.
187. Sommer U, Liu H, Doering TL. 2003. An alpha-1,3-mannosyltransferase of Cryptococcus neoformans. J. Biol. Chem. 278:47724-47730.
188. Song M-H, et al. 2012. A flucytosine-responsive Mbp1/Swi4-like protein, Mbs1, plays pleiotropic roles in antifungal drug resistance, stress response, and virulence of Cryptococcus neoformans. Eukaryot. Cell 11: 53-67.
189. Speed B, Dunt D. 1995. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin. Infect. Dis. 21:28-34.
190. Spiropulu C, Eppard RA, Otteson E, Kozel TR. 1989. Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide. Infect. Immun. 57:3240-3242.
191. Steenbergen JN, Casadevall A. 2003. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect. 5:667-675.
192. Steenbergen JN, Nosanchuk JD, Malliaris SD, Casadevall A. 2003. Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum. Infect. Immun. 71:4862-4872.
193. Stephen C, Lester S, Black W, Fyfe M, Raverty S. 2002. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can. Vet. J. 43:792-794.
194. Tanaka K-I, Nambu H, Katoh Y, Kai M, Hidaka Y. 1999. Molecular cloning of homologs of RAS and RHO1 genes from Cryptococcus neoformans. Yeast 15:1133-1139.
195. Tangen KL, Jung WH, Sham AP, Lian T, Kronstad JW. 2007. The ironand cAMP-regulated gene SIT1 influences ferrioxamine B utilization, melanization and cell wall structure in Cryptococcus neoformans. Microbiology 153:29-41.
196. Thompson JR, et al. 1999. A glucan synthase FKS1 homolog in Cryptococcus neoformans is single copy and encodes an essential function. J. Bacteriol. 181:444-453.
197. Tucker SC, Casadevall A. 2002. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc. Natl. Acad. Sci. U. S. A. 99:3165-3170.
198. Vartivarian SE. 1992. Virulence properties and nonimmune pathogenetic mechanisms of fungi. Clin. Infect. Dis. 14:S30-S36.
199. Vartivarian SE, et al. 1993. Regulation of cryptococcal capsular polysaccharide by iron. J. Infect. Dis. 167:186-190.
200. Vecchiarelli A, et al. 2003. The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation. J. Leukoc. Biol. 74:370-378.
201. Vecchiarelli A, et al. 1995. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect. Immun. 63:2919-2923.
202. Vincent O, Rainbow L, Tilburn J, Arst HN, Jr, Penalva MA. 2003. YPXL/I is a protein interaction motif recognized by Aspergillus PalA and its human homologue, AIP1/Alix. Mol. Cell. Biol. 23:1647-1655.
203. Voisard C, Wang J, McEvoy JL, Xu P, Leong SA. 1993. Urbs1, a gene regulating siderophore biosynthesis in Ustilago maydis, encodes a protein similar to the erythroid transcription factor GATA-1. Mol. Cell. Biol. 13:7091-7100.
204. Walton FJ, Heitman J, Idnurm A. 2006. Conserved elements of the RAMsignaling pathway establish cell polarity in the basidiomycete Cryptococcus neoformans in a divergent fashion from other fungi. Mol. Biol. Cell 17:3768-3780.
205. Walton FJ, Idnurm A, Heitman J. 2005. Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans. Mol. Microbiol. 57:1381-1396.
206. Wang A, Kurdistani SK, Grunstein M. 2002. Requirement of Hos2 histone deacetylase for gene activity in yeast. Science 298:1412-1414.
207. Wang L-I, Lin Y-S, Liu K-H, Jong AY, Shen W-C. 2011. Cryptococcus neoformans mediator protein Ssn8 negatively regulates diverse physiological processes and is required for virulence. PLoS One 6:e19162. doi: 10.1371/journal.pone.0019162.
208. Wang P, Cox GM, Heitman J. 2004. A Sch9 protein kinase homologue controlling virulence independently of the cAMP pathway in Cryptococcus neoformans. Curr. Genet. 46:247-255.
209. Wang Y, Liu TB, Patel S, Jiang L, Xue C. 2011. The casein kinase I protein Cck1 regulates multiple signaling pathways and is essential for cell integrity and fungal virulence in Cryptococcus neoformans. Eukaryot. Cell 10:1455-1464.
210. Weinberg ED. 1978. Iron and infection. Microbiol. Mol. Biol. Rev. 42: 45-66.
211. Weinberg ED. 2009. Iron availability and infection. Biochim. Biophys. Acta 1790:600-605.
212. Weinberg ED. 1999. The role of iron in protozoan and fungal infectious diseases. J. Eukaryot. Microbiol. 46:231-238.
213. Willger SD, Ernst JF, Alspaugh JA, Lengeler KB. 2009. Characterization of the PMT gene family in Cryptococcus neoformans. PLoS One 4:e6321. doi:10.1371/journal.pone.0006321.
214. Wills EA, et al. 2001. Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity. Mol. Microbiol. 40:610-620.
215. Xu J, Mitchell TG. 2003. Comparative gene genealogical analyses of strains of serotype AD identify recombination in populations of serotypes A and D in the human pathogenic yeast Cryptococcus neoformans. Microbiology 149:2147-2154.
216. Xu J, Vilgalys R, Mitchell TG. 2000. Multiple gene genealogies reveal recent dispersion and hybridization in the human pathogenic fungus Cryptococcus neoformans. Mol. Ecol. 9:1471-1481.
217. Xu W, Mitchell AP. 2001. Yeast PalA/AIP1/Alix homolog Rim20p associates with a PEST-like region and is required for its proteolytic cleavage. J. Bacteriol. 183:6917-6923.
218. Xue C, Bahn Y-S, Cox GM, Heitman J. 2006. G protein-coupled receptor Gpr4 senses amino acids and activates the cAMP-PKA pathway in Cryptococcus neoformans. Mol. Biol. Cell 17:667-679.
219. Xue C, Hsueh Y-P, Chen L, Heitman J. 2008. The RGS protein Crg2 regulates both pheromone and cAMP signalling in Cryptococcus neoformans. Mol. Microbiol. 70:379-395.
220. Yoneda A, Doering TL. 2006. A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis. Mol. Biol. Cell 17:5131-5140.
221. Yoneda A, Doering TL. 2008. Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level. Eukaryot. Cell 7:546-549.
222. Zapater M, Sohrmann M, Peter M, Posas F, de Nadal E. 2007. Selective requirement for SAGA in Hog1-mediated gene expression depending on the severity of the external osmostress conditions. Mol. Cell. Biol. 27: 3900-3910.
223. Zaragoza O, Casadevall A. 2004. Experimental modulation of capsule size in Cryptococcus neoformans. Biol. Proced. Online 6:10-15.
224. Zaragoza O, et al. 2008. Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell. Microbiol. 10:2043-2057.
225. Zaragoza O, Fries BC, Casadevall A. 2003. Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO2. Infect. Immun. 71:6155-6164.
226. Zaragoza O, et al. 2010. Fungal cell gigantism during mammalian infection. PLoS Pathog. 6:e1000945. doi:10.1371/journal.ppat.1000945.
227. Zaragoza O, Telzak A, Bryan RA, Dadachova E, Casadevall A. 2006. The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding. Mol. Microbiol. 59:67-83.
228. Zhang S, et al. 2006. The Hsp70 member, Ssa1, acts as a DNA-binding transcriptional co-activator of laccase in Cryptococcus neoformans. Mol. Microbiol. 62:1090-1101.
229. Zhu X, Williamson PR. 2003. A CLC-type chloride channel gene is required for laccase activity and virulence in Cryptococcus neoformans. Mol. Microbiol. 50:1271-1281.
230. Zippin JH, Levin LR, Buck J. 2001. CO2/HCO3-responsive soluble adenylyl cyclase as a putative metabolic sensor. Trends Endocrinol. Metab. 12:366-370.